Publication: Oral Immunotherapy for Food Allergy: A Spanish Guideline. Egg and Milk Immunotherapy Spanish Guide (ITEMS GUIDE). Part II: Maintenance Phase of Cow Milk (CM) and Egg Oral Immunotherapy (OIT), Special Treatment Dosing Schedules. Models of Dosing Schedules of OIT With CM and Egg.
No Thumbnail Available
Identifiers
Date
2017-06-08
Authors
Martorell, A
Alonso, E
Echeverría, L
Escudero, C
García-Rodríguez, R
Blasco, C
Bone, J
Borja-Segade, J
Bracamonte, T
Claver, A
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Cow milk and egg are the most frequent causes of food allergy in the first years of life. Oral immunotherapy (OIT) has been investigated as an alternative to avoidance diets. No clinical practice guidelines on the management of OIT with milk and egg are currently available. Objectives: To develop clinical guidelines for OIT based on available scientific evidence and the opinions of experts. A review was made of studies published between 1984 and June 2016, doctoral theses published in Spain, summaries of communications at scientific meetings (SEAIC, SEICAP, EAACI, and AAAAI), and the consensus of opinion established by a group of experts from the scientific societies SEICAP and SEAIC. Recommendations were established regarding the indications, requirements and practical aspects of the different phases of OIT, as well as special protocols for patients at high risk of adverse reactions. Clinical practice guidelines based on the consensus reached between Spanish experts are presented for the management of OIT with milk and egg.
Description
MeSH Terms
Administration, Oral
Allergens
Animals
Desensitization, Immunologic
Disease Management
Egg Hypersensitivity
Food Hypersensitivity
Humans
Milk Hypersensitivity
Spain
Allergens
Animals
Desensitization, Immunologic
Disease Management
Egg Hypersensitivity
Food Hypersensitivity
Humans
Milk Hypersensitivity
Spain
DeCS Terms
CIE Terms
Keywords
Desensitization, Egg allergy, Guide, Milk allergy, Omalizumab, Oral immunotherapy, Specific oral tolerance induction, Sublingual immunotherapy